Master Alliance Provisions Guide (MAPGuide)

University of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement

  • Liability | Indemnification & liability


6.1. Treatment of Confidential Information. Each of the Parties shall ensure that, during the ten (10) years from the Effective Date, the Confidential Information:

i. shall be used in a reserved manner.

ii. shall not be copied or disclosed in whole or in part by or to Third Parties without having obtained the express written authorization from the Disclosing Party, except that such written authorization shall not be necessary in the following instances:

(i.) Regulatory filings;

(ii.) Prosecuting or defending litigation;

(iii.) Complying with applicable governmental laws and regulations; and

(iv.) Disclosure in connection with this Agreement to its staff, consultants, advisors and non-voting Board Members, subcontractors, or Sublicensees on a “need to-know” basis and using the same diligence and confidentiality as that used by the Receiving Party in protecting its own proprietary information;

iii. shall not be used in whole or in part for any purpose other than the execution of this Agreement;

The Parties shall be liable to each other for breach of this obligation, whether by its employees, associates, Sublicensees or any other person to whom the Confidential Information was disclosed.

In the event that there is current legislation on the protection of personal data, the Parties declare their recognition and respect for it.